(Total Views: 575)
Posted On: 04/15/2023 1:04:42 PM
Post# of 72451
3/15/2023 - Testing of Brilacidin by NIH/NIAID Affiliated and Other Academic Researchers
https://www.marketscreener.com/quote/stock/IN...-43271215/
Across all pre-clinical studies conducted to date, Brilacidin has now exhibited varying degrees of inhibition against 13 of 19 “priority” fungal pathogens identified by the World Health Organization in need of novel treatments. Summary of Research Results: Comparable to findings observed in testing by scientists at the University of Sao Paulo (USP), Brazil, Brilacidin showed potent stand-alone inhibition in multiple isolates of C. neoformans, for which few effective treatments exist. C. neoformans causes approximately 220,000 cases of cryptococcal meningitis worldwide each year and is associated with an 80% mortality rate.
https://www.marketscreener.com/quote/stock/IN...-43271215/
Across all pre-clinical studies conducted to date, Brilacidin has now exhibited varying degrees of inhibition against 13 of 19 “priority” fungal pathogens identified by the World Health Organization in need of novel treatments. Summary of Research Results: Comparable to findings observed in testing by scientists at the University of Sao Paulo (USP), Brazil, Brilacidin showed potent stand-alone inhibition in multiple isolates of C. neoformans, for which few effective treatments exist. C. neoformans causes approximately 220,000 cases of cryptococcal meningitis worldwide each year and is associated with an 80% mortality rate.
(2)
(0)
